Concepedia
Statistics
Publications
17
Citations
584
H-Index
14
Active since
2010
Affiliations
Oslo University Hospital(Current)
Oregon Health & Science University
University of Pennsylvania
University of Minnesota
Novartis (United States)
Lamis Eldjerou is an author at Oslo University Hospital specializing in medicine, hematology, and oncology.
Publications per year
2010–2024
Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia
Stephan A. Grupp, Shannon L. Maude, Susana Rives et al. · Blood · 2018 · 93 citations
Medicine, Hematology, Oncology +12
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
John E. Levine, Stephan A. Grupp, Michael A. Pulsipher et al. · Journal for ImmunoTherapy of Cancer · 2021 · 64 citations · Full text
Medicine, Hematology, Oncology +17
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy
Jochen Buechner, Stephan A. Grupp, Hidefumi Hiramatsu et al. · Blood Advances · 2021 · 59 citations · Full text
Medicine, Hematology, Immunology +14
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment
Lamis Eldjerou, Sonali Chaudhury, Mai He et al. · Blood · 2010 · 51 citations · Full text
Medicine, Hematology, Stem Cell Transplantation +15
GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.
Monrat Chulanetra, Atthapan Morchang, Elias Sayour et al. · PubMed · 2020 · 47 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 17